Tolins J P
Department of Medicine, University of Minnesota School of Medicine.
J Lab Clin Med. 1992 Dec;120(6):941-8.
The mechanisms underlying the renal hemodynamic responses (vasodilation and hyperfiltration) to an amino acid or protein load are currently unknown and are relevant to understanding the effect of dietary protein on the progression of chronic renal failure. Glucagon (GLC) has been suggested to be important in these renal hemodynamic responses, although the mechanism is again unclear. Thus we investigated potential mediators of the renal hemodynamic response to GLC in the anesthetized rat, including prostanoids and endothelium-derived relaxing factor (EDRF). The effects of glucagon alone and after pretreatment were tested as follows: (1) after baseline renal hemodynamic measurements done with clearance techniques, rats were given GLC alone (n = 5; 200 ng/min IV continuous infusion); (2) glucagon was given after pretreatment with the EDRF synthesis inhibitor nitro-arginine-methyl-ester (NAME; n = 6; 125 micrograms/kg/min intrarenal artery by continuous infusion); (3) glucagon was given after pretreatment with indomethacin (INDO; n = 6; 5 mg/kg IV bolus). Repeat clearances demonstrated that GLC infusion increased glomerular filtration rate (GFR; basal vs GLC, 0.87 +/- 0.04 ml/min vs 1.14 +/- 0.09 ml/min, p < 0.05); renal plasma flow (RPF; 4.10 +/- 0.18 ml/min vs 5.56 +/- 0.32 ml/min, p < 0.05) and decreased renal vascular resistance (RVR; 15.82 +/- 1.17 mm Hg/[ml/min] vs 10.72 +/- 0.65 mm Hg/[ml/min], p < 0.05). Intrarenal N-nitro-L-arginine-methyl-ester (NAME) infusion significantly reduced basal GFR (-20% +/- 8%, p < 0.05) and RPF (-43% +/- 2%, p < 0.05), while increasing RVR (+108% +/- 9%, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
氨基酸或蛋白质负荷引起肾血流动力学反应(血管舒张和超滤)的潜在机制目前尚不清楚,这与理解膳食蛋白质对慢性肾衰竭进展的影响相关。尽管机制仍不明确,但已表明胰高血糖素(GLC)在这些肾血流动力学反应中起重要作用。因此,我们在麻醉大鼠中研究了对GLC的肾血流动力学反应的潜在介质,包括前列腺素和内皮源性舒张因子(EDRF)。单独给予胰高血糖素及其预处理后的效果测试如下:(1)用清除技术进行基线肾血流动力学测量后,单独给予大鼠GLC(n = 5;200 ng/min静脉持续输注);(2)在用EDRF合成抑制剂N-硝基-L-精氨酸甲酯(NAME;n = 6;125微克/千克/分钟通过肾动脉持续输注)预处理后给予胰高血糖素;(3)在用吲哚美辛(INDO;n = 6;5毫克/千克静脉推注)预处理后给予胰高血糖素。重复清除显示,输注GLC可增加肾小球滤过率(GFR;基础值与GLC相比,0.87±0.04毫升/分钟对1.14±0.09毫升/分钟,p<0.05);肾血浆流量(RPF;4.10±0.18毫升/分钟对5.56±0.32毫升/分钟,p<0.05)并降低肾血管阻力(RVR;15.